These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 8567774)

  • 61. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Depressive symptoms and Norplant contraceptive implants.
    Westhoff C; Truman C; Kalmuss D; Cushman L; Rulin M; Heartwell S; Davidson A
    Contraception; 1998 Apr; 57(4):241-5. PubMed ID: 9649915
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Norplant implants: the mechanism of contraceptive action.
    Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C; Nillius SJ; Wide L; Lindgren A
    Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Experience of Thai women in Bangkok with Norplant-2 implants.
    Chompootaweep S; Kochagarn E; Tang-Usaha J; Theppitaksak B; Dusitsin N
    Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contraception with progestogens and progesterone during lactation.
    Shaaban MM
    J Steroid Biochem Mol Biol; 1991; 40(4-6):705-10. PubMed ID: 1835650
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Norplant subdermal contraceptive system: experience in Taiwan.
    Tseng LH; Lee TY; Yang YS; Ko TM; Chuang SM
    Contraception; 1996 Mar; 53(3):177-80. PubMed ID: 8689883
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
    Landgren BM; Johannisson E; Xing S; Aedo AR; Diczfalusy E
    Contraception; 1985 Dec; 32(6):581-601. PubMed ID: 3937664
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Blood-lipid fractions: the side-effects and continuation of Norplant use.
    Noerpramana NP
    Adv Contracept; 1997 Mar; 13(1):13-37. PubMed ID: 9181182
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
    Croxatto HB; Díaz S; Pavez M; Brandeis A
    Contraception; 1988 Oct; 38(4):465-75. PubMed ID: 3145171
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
    Contraception; 1993 Aug; 48(2):120-32. PubMed ID: 8403909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
    Rogers PA; Au CL; Affandi B
    Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
    Mäkäräinen L; van Beek A; Tuomivaara L; Asplund B; Coelingh Bennink H
    Fertil Steril; 1998 Apr; 69(4):714-21. PubMed ID: 9548163
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of Norplant implants in asymptomatic HIV-1 infected women.
    Taneepanichskul S; Intaraprasert S; Phuapradit W; Chaturachinda K
    Contraception; 1997 Apr; 55(4):205-7. PubMed ID: 9179451
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
    Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
    Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.